These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27385398)

  • 1. Impact of comorbidity and anemia in patients with oropharyngeal cancer primarily treated with surgery in the human papillomavirus era.
    Baumeister P; Rauch J; Jacobi C; Kisser U; Betz C; Becker S; Reiter M
    Head Neck; 2017 Jan; 39(1):7-16. PubMed ID: 27385398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
    Park WS; Ryu J; Cho KH; Choi MK; Moon SH; Yun T; Chun BS; Lee GK; Ahn HJ; Lee JH; Vermeer P; Jung YS
    Head Neck; 2012 Oct; 34(10):1408-17. PubMed ID: 22052559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer.
    Wuerdemann N; Wittekindt C; Sharma SJ; Prigge ES; Reuschenbach M; Gattenlöhner S; Klussmann JP; Wagner S
    Oncol Res Treat; 2017; 40(6):320-327. PubMed ID: 28558385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-Pk
    Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
    Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
    Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
    J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
    Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary treatment for oropharyngeal squamous cell carcinoma in Alberta, Canada: A population-based study.
    Hobbs AJ; Brockton NT; Matthews TW; Chandarana SP; Bose P; Guggisberg K; Fick GH; Dort JC
    Head Neck; 2017 Nov; 39(11):2187-2199. PubMed ID: 28782304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma.
    Ukpo OC; Flanagan JJ; Ma XJ; Luo Y; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2011 Sep; 35(9):1343-50. PubMed ID: 21836494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of discordant human papillomavirus and p16 oropharyngeal squamous cell carcinomas in an African American cohort.
    Liu JC; Parajuli S; Blackman E; Gibbs D; Ellis A; Hull A; Beck JR; Giri V; Iherjirka P; Khurana JS; Ragin CR
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E867-72. PubMed ID: 25962720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival.
    Cai C; Chernock RD; Pittman ME; El-Mofty SK; Thorstad WL; Lewis JS
    Am J Surg Pathol; 2014 Jun; 38(6):809-15. PubMed ID: 24698966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery.
    Broglie MA; Stoeckli SJ; Sauter R; Pasche P; Reinhard A; de Leval L; Huber GF; Pezier TF; Soltermann A; Giger R; Arnold A; Dettmer M; Arnoux A; Müller M; Spreitzer S; Lang F; Lutchmaya M; Stauffer E; Espeli V; Martucci F; Bongiovanni M; Foerbs D; Jochum W
    Head Neck; 2017 Oct; 39(10):2004-2015. PubMed ID: 28691255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of positive margins on outcomes of oropharyngeal squamous cell carcinoma according to p16 status.
    Molony P; Kharytaniuk N; Boyle S; Woods RSR; O'Leary G; Werner R; Heffron C; Feeley L; Sheahan P
    Head Neck; 2017 Aug; 39(8):1680-1688. PubMed ID: 28560813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing p16 Status of Oropharyngeal Squamous Cell Carcinoma by Combined Assessment of the Number of Cells Stained and the Confluence of p16 Staining: A Validation by Clinical Outcomes.
    Barasch S; Mohindra P; Hennrick K; Hartig GK; Harari PM; Yang DT
    Am J Surg Pathol; 2016 Sep; 40(9):1261-9. PubMed ID: 27186851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival.
    Näsman A; Nordfors C; Grün N; Munck-Wikland E; Ramqvist T; Marklund L; Lindquist D; Dalianis T
    Cancer Med; 2013 Aug; 2(4):507-18. PubMed ID: 24156023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between HPV-DNA status and p16 protein expression in oropharyngeal squamous cell carcinoma and their clinical significance].
    Huang H; Zhang B; Chen W; Zou SM; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):684-8. PubMed ID: 24332056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Importance of Comorbidity and the Association Between Comorbidity and p16 in Oropharyngeal Squamous Cell Carcinoma.
    Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):568-75. PubMed ID: 27077485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer.
    Wagner S; Wittekindt C; Sharma SJ; Wuerdemann N; Jüttner T; Reuschenbach M; Prigge ES; von Knebel Doeberitz M; Gattenlöhner S; Burkhardt E; Pons-Kühnemann J; Klussmann JP
    Br J Cancer; 2017 Jun; 116(12):1604-1611. PubMed ID: 28472822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.
    Nichols AC; Faquin WC; Westra WH; Mroz EA; Begum S; Clark JR; Rocco JW
    Otolaryngol Head Neck Surg; 2009 Feb; 140(2):228-34. PubMed ID: 19201294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.